Frontlight ResearchEarly access
Trial site
Gunma Prefectural Cancer Center
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer2 trials
- Ovarian cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Diffuse large B-cell lymphoma1 trial
- Lung cancer1 trial
- Mesothelioma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Genmab2 trials
- ADC Therapeutics S.A.1 trial
- Japanese Gynecologic Oncology Group1 trial
- Pfizer1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Recruiting
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Active, not recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer2 recruiting
- Ovarian cancer2 recruiting
- Cervical cancer1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026